Analysts expect that Ceridian HCM Holding Inc (NYSE:CDAY) will report earnings of $0.11 per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Ceridian HCM’s earnings. The lowest EPS estimate is $0.10 and the highest is $0.13. Ceridian HCM reported earnings of $0.07 per share in the same quarter last year, which would suggest a positive year over year growth rate of 57.1%. The firm is scheduled to announce its next earnings results on Wednesday, February 5th.

On average, analysts expect that Ceridian HCM will report full-year earnings of $0.59 per share for the current financial year, with EPS estimates ranging from $0.47 to $1.00. For the next fiscal year, analysts forecast that the business will report earnings of $0.69 per share, with EPS estimates ranging from $0.58 to $0.84. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow Ceridian HCM.

Ceridian HCM (NYSE:CDAY) last announced its earnings results on Thursday, November 7th. The company reported $0.11 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.07 by $0.04. The company had revenue of $202.30 million during the quarter, compared to the consensus estimate of $196.52 million. Ceridian HCM had a net margin of 11.34% and a return on equity of 2.24%. Ceridian HCM’s revenue was up 13.6% compared to the same quarter last year. During the same period last year, the firm earned $0.10 earnings per share.

CDAY has been the subject of several research reports. Cantor Fitzgerald initiated coverage on shares of Ceridian HCM in a research note on Wednesday, September 11th. They set an “overweight” rating and a $65.00 price objective for the company. Zacks Investment Research downgraded shares of Ceridian HCM from a “buy” rating to a “hold” rating in a research note on Monday, October 21st. Jefferies Financial Group upgraded shares of Ceridian HCM from a “hold” rating to a “buy” rating and boosted their target price for the company from $58.00 to $65.00 in a research report on Monday, August 19th. ValuEngine downgraded shares of Ceridian HCM from a “buy” rating to a “hold” rating in a research report on Wednesday, September 4th. Finally, Mizuho set a $65.00 target price on shares of Ceridian HCM and gave the company a “buy” rating in a research report on Friday, September 6th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $57.15.

In other Ceridian HCM news, CEO David D. Ossip sold 500,000 shares of Ceridian HCM stock in a transaction on Friday, September 6th. The shares were sold at an average price of $56.00, for a total value of $28,000,000.00. Also, Director Cannae Holdings, Inc. sold 5,000,000 shares of Ceridian HCM stock in a transaction on Friday, November 15th. The shares were sold at an average price of $53.08, for a total transaction of $265,400,000.00. The disclosure for this sale can be found here. Insiders have sold 12,006,250 shares of company stock valued at $657,725,063 over the last 90 days. 26.90% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD increased its holdings in Ceridian HCM by 31.4% in the second quarter. Price T Rowe Associates Inc. MD now owns 13,864,672 shares of the company’s stock valued at $696,007,000 after buying an additional 3,312,089 shares in the last quarter. Select Equity Group L.P. increased its holdings in Ceridian HCM by 32.4% in the third quarter. Select Equity Group L.P. now owns 8,434,199 shares of the company’s stock valued at $416,396,000 after buying an additional 2,064,472 shares in the last quarter. Vanguard Group Inc. increased its holdings in Ceridian HCM by 30.9% in the second quarter. Vanguard Group Inc. now owns 6,487,533 shares of the company’s stock valued at $325,674,000 after buying an additional 1,531,004 shares in the last quarter. BlackRock Inc. increased its holdings in Ceridian HCM by 28.6% in the second quarter. BlackRock Inc. now owns 2,913,790 shares of the company’s stock valued at $146,271,000 after buying an additional 647,177 shares in the last quarter. Finally, Bamco Inc. NY increased its holdings in Ceridian HCM by 8.2% in the second quarter. Bamco Inc. NY now owns 2,562,171 shares of the company’s stock valued at $128,621,000 after buying an additional 195,002 shares in the last quarter. 82.99% of the stock is owned by institutional investors.

Shares of NYSE:CDAY traded up $0.01 on Monday, hitting $60.37. 1,067,000 shares of the company were exchanged, compared to its average volume of 973,106. Ceridian HCM has a 1-year low of $31.39 and a 1-year high of $61.15. The stock’s 50 day moving average price is $52.25 and its 200 day moving average price is $51.64. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $8.69 billion, a P/E ratio of -1,207.40 and a beta of 1.57.

About Ceridian HCM

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

Recommended Story: Limitations to arbitrage trading

Get a free copy of the Zacks research report on Ceridian HCM (CDAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com